$blte
$BLTE sees a massive 152% surge in engagements over the past week, driven by positive sentiment and discussions around biopharma catalysts and investment success. The cryptocurrency is experiencing a significant uptick in social media attention.
About $blte
$BLTE is a cryptocurrency.
Insights
- $blte engagements is up 152.14% from the previous week.
Engagements: [-----] (24h)
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [-----]
[--] Week: [-----] +152%
[--] Month: [-------] -11%
[--] Months: [-------] +95%
[--] Year: [---------] +114%
1-Year High: [-------] on 2025-08-11
1-Year Low: [--] on 2025-02-18
Engagements by network (24h): X: [-----]
Mentions: [--] (24h)
Mentions 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-02-18
Mentions by network (24h): X: [--]
Creators: [--] (24h)
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning $blte in the last [--] hours which is no change from in the previous [--] hours
Daily Average: [--]
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-02-18
The most influential creators that mention $blte in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @Andre_AGTC | [--] | [-----] | [--] | [---] |
| @SteveDJacobs | [--] | [------] | [--] | [---] |
| @rynltmymy873300 | [--] | [--] | [--] | [--] |
| @biotecharutaka | [--] | [---] | [--] | [--] |
Sentiment: 100%
Sentiment 24-Hour Time-Series Raw Data
Current Value: 100%
Daily Average: 81%
[--] Week: 100% no change
[--] Month: 89% +6%
[--] Months: 89% +22%
[--] Year: 89% -11%
1-Year High: 100% on 2025-02-19
1-Year Low: 29% on 2025-11-06
Most Supportive Themes:
- Andre AGTC Year-End Update: (74%) This comprehensive update lists numerous stocks across various therapeutic areas and indications, with BLTE mentioned.
- Andre AGTC ATH: (23%) This post highlights personal investment success with multiple stocks hitting all-time highs, including BLTE.
- Biopharma Watch: (3%) This post discusses an upcoming FDA catalyst for Tinlarebant (LBS-008) for Stargardt disease type [--].
Most Critical Themes:
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing